Suppliers / Juno Pharmaceuticals

Juno Pharmaceuticals

Canada 13 employees Updated 9 July 2026

Juno Pharmaceuticals is a finished-dose manufacturer based in Canada. It appears in 136 regulatory filings across 3 regulators, without an active US DMF or CEP on file. Its filings concentrate with Health Canada, MEDSAFE (NZ) and TGA (Australia).

0
active US DMFs
0
valid CEPs
0
registered plants
136
filings across 3 regulators

Filings and GMP by regulator

Regulator Filings GMP certificates
Health Canada 80 None
MEDSAFE (NZ) 55 None
TGA (Australia) 1 None

Limited public record

Beyond the filing counts above, the public registers hold no plant, inspection or portfolio detail for this company as at 9 July 2026. We report that as a gap rather than inferring an answer.

Questions about Juno Pharmaceuticals

Does Juno Pharmaceuticals hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Juno Pharmaceuticals. It does have 136 filings with 3 regulators, so it is registered, just not with the two strong registers buyers usually screen on.
Where does Juno Pharmaceuticals file?
Filings are on record with Health Canada, MEDSAFE (NZ) and TGA (Australia), 136 in total.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Juno Pharmaceuticals comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability